| RS2518153097 |
ITSN1
|
Health Risk |
Likely pathogenic |
Generalized-onset seizure, Generalized-onset seizure |
| RS2518153183 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518153329 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518153447 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518160258 |
CACNA1I
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech impairment and with or without seizures, Neurodevelopmental disorder with speech impairment and with or without seizures |
| RS2518161108 |
TRIOBP
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2518162094 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518162180 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518162686 |
TRMU
|
Health Risk |
Pathogenic/Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518170070 |
SF3A1
|
Health Risk |
Pathogenic |
Malignant lymphoma, large B-cell |
| RS2518177413 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS2518178649 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518179076 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518179155 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518179292 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518179911 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518179937 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518182063 |
CACNA1I
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with speech impairment and with or without seizures, Neurodevelopmental disorder with speech impairment and with or without seizures |
| RS2518188382 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS2518189757 |
ACO2
|
Health Risk |
Likely pathogenic |
Optic atrophy 9, Optic atrophy |
| RS2518189759 |
ACO2
|
Health Risk |
Likely pathogenic |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS2518190654 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518190941 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518191775 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518191972 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518195149 |
TRIOBP
|
Health Risk |
Pathogenic |
— |
| RS2518196896 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518196909 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518197535 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2518199038 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS2518201260 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518201331 |
TRMU
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Germ cell tumor of testis |
| RS2518201350 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518201351 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518201657 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518202100 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518202141 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518202180 |
TRMU
|
Health Risk |
Likely pathogenic |
Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2518202192 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518202230 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518202814 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518204649 |
TCF20
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518209232 |
TCF20
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518210719 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518210728 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518210879 |
TCF20
|
Health Risk |
Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518210953 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518211131 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518211177 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518211256 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518211384 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518211396 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518211501 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518211598 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518211627 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2518211759 |
TCF20
|
Health Risk |
Pathogenic |
— |
| RS2518212002 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518212222 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS2518212238 |
TRMU
|
Health Risk |
Likely pathogenic |
— |
| RS2518212988 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518215402 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518215957 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins |
| RS2518216310 |
TRMU
|
Health Risk |
Pathogenic |
— |
| RS2518216660 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518216788 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518216846 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518217148 |
TCF20
|
Health Risk |
Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518218275 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518219983 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518222254 |
ACO2
|
Health Risk |
Likely pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS2518222390 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518222528 |
TCF20
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Autism spectrum disorder |
| RS2518222791 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518222824 |
TCF20
|
Health Risk |
Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518223057 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518223366 |
TRMU
|
Health Risk |
Likely pathogenic |
Aminoglycoside-induced deafness, Aminoglycoside-induced deafness |
| RS2518223728 |
PCNT
|
Health Risk |
Likely pathogenic |
Microcephalic osteodysplastic primordial dwarfism type II, Microcephalic osteodysplastic primordial dwarfism type II |
| RS2518223988 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518224183 |
PCNT
|
Health Risk |
Pathogenic |
— |
| RS2518224688 |
ACO2
|
Health Risk |
Pathogenic |
Infantile cerebellar-retinal degeneration, Infantile cerebellar-retinal degeneration |
| RS2518225113 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS2518225140 |
TCF20
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518225484 |
SERPIND1
|
Health Risk |
Likely pathogenic |
Hemorrhage, Hemorrhage |
| RS2518225685 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS2518225761 |
TRIOBP
|
Health Risk |
Likely pathogenic |
TRIOBP-related disorder, TRIOBP-related disorder |
| RS2518225830 |
NF2
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2518225875 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518227349 |
ACO2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2518227378 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518228232 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS2518228363 |
HPS4
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 4, Hermansky-Pudlak syndrome 4 |
| RS2518228505 |
DEPDC5
|
Health Risk |
Pathogenic |
Epilepsy, familial focal |
| RS2518229209 |
HPS4
|
Health Risk |
Pathogenic |
— |
| RS2518229658 |
ACO2
|
Health Risk |
Likely pathogenic |
— |
| RS2518229660 |
DEPDC5
|
Health Risk |
Likely pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2518229756 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518229785 |
ACO2
|
Health Risk |
Pathogenic |
Optic atrophy 9, Optic atrophy 9 |
| RS2518230173 |
TCF20
|
Health Risk |
Pathogenic |
Developmental delay with variable intellectual impairment and behavioral abnormalities, Developmental delay with variable intellectual impairment and behavioral abnormalities |
| RS2518230292 |
ACO2
|
Health Risk |
Pathogenic |
— |
| RS2518231025 |
TCF20
|
Health Risk |
Likely pathogenic |
TCF20-related disorder, TCF20-related disorder |